"Thanks to immunotherapy, and other therapies, the treatment of cancer is becoming more successful"
Immunotherapy is gaining ground in the fight against cancer. The tumour has a strategy to evade detection by the immune system, thus allowing it to spread throughout the body. Science has discovered this therapy and is working on overcoming this evasion strategy. In this regard, La República has published an interview with Eduard Batlle, head of the Colorectal Cancer Lab at IRB Barcelona.
Related content
News
Researchers at IRB Barcelona discover a new mechanism in estrogen receptor-positive breast cancer cells.
The inhibition of CPEB2, a key factor in the estrogen signalling pathway, causes cancer cells to proliferate less and protects mice against luminal breast cancer.
Several media channels have reported on the award of European Research Council funding to various projects being undertaken in Catalonia. Among these projects is that of Eduard Batlle, head of the Colorectal cancer Lab at IRB Barcelona. His research will focus on the hidden cells of the primary tumour that begin to spread before surgical intervention and that can remain undetectable for months or years until they seed a new tumour.
Batlle will study the distinct mechanisms through which these cells evade the immune system and invade another organ.
To mark World Cancer Day, the programme El Matí de Barcelona Betevé broadcasted by Radio Barcelona has interviewed Roger Gomis, ICREA Researcher and head of the Growth Control and Metastasis Lab at IRB Barcelona. During the interview, he talked about metastasis, the process by which a tumour spreads to the rest of the body, allowing cancer cells to adapt to new environments “What we are focusing on in our lab is precisely how this cell adaptation and plasticity comes about,” says Gomis.
